Phentermine–topiramate extended-release reduces progression to T2DM

被引：0
|
作者：
机构：
来源：
Nature Reviews Endocrinology | 2014年 / 10卷 / 1期
关键词：
D O I：
10.1038/nrendo.2013.217
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [1] Evaluation of Phentermine and Topiramate versus Phentermine/Topiramate Extended-Release in Obese Adults
    Aronne, Louis J.
    Wadden, Thomas A.
    Peterson, Craig
    Winslow, David
    Odeh, Sarah
    Gadde, Kishore M.
    OBESITY, 2013, 21 (11) : 2163 - 2171
  • [2] BUDGET IMPACT OF PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE (PHEN/TPM ER) IN OVERWEIGHT AND OBESE PATIENTS WITH COMORBID PREDIABETES OR TYPE 2 DIABETES MELLITUS (T2DM)
    Zagadailov, E.
    Carlton, R.
    Bramley, T.
    Liu, W.
    Karnawat, S.
    McDowell, J.
    VALUE IN HEALTH, 2014, 17 (03) : A242 - A242
  • [3] Effects of phentermine and extended-release topiramate alone and in combination on cardiovascular risk factors
    Jordan, J.
    Astrup, A. V.
    Day, W. W.
    DIABETOLOGIA, 2012, 55 : S285 - S286
  • [4] Effects of Low-Dose, Controlled-Release Phentermine/Topiramate (PHEN/TPM) on Weight, Glycemic Markers, and Progression to Type 2 Diabetes Mellitus (T2DM)
    Ryan, Donna H.
    Gadde, Kishore
    Wilson, Leland F.
    Troupin, Barbara
    DIABETES, 2010, 59 : A491 - A491
  • [5] Low-Dose, Controlled-Release Phentermine/Topiramate (PHEN/TPM) and Markers of Type 2 Diabetes Mellitus (T2DM)
    Ryan, Donna H.
    Gadde, Kishore
    Troupin, Barbara
    Tam, Peter
    DIABETES, 2010, 59 : A482 - A482
  • [6] WEIGHT LOSS WITH PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE IN OBESE AND OVERWEIGHT SUBJECTS OVER 56 WEEKS
    Kushner, Robert F.
    Varghese, Santosh T.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 : S241 - S241
  • [7] Combination phentermine and topiramate extended release in the management of obesity
    Alfaris, Nasreen
    Minnick, Alyssa M.
    Hopkins, Christina M.
    Berkowitz, Robert I.
    Wadden, Thomas A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (08) : 1263 - 1274
  • [8] Effects of extended-release phentermine/topiramate on weight loss and blood pressure in obese subjects with type 2 diabetes mellitus
    Rossner, S. K.
    Sharma, A. M.
    Troupin, B.
    Padwal, R. S.
    DIABETOLOGIA, 2012, 55 : S285 - S285
  • [9] SAXAGLIPTIN/METFORMIN EXTENDED-RELEASE (XR) FOR THE TYPE 2 DIABETES (T2DM) TREATMENT IN VENEZUELA: A BUDGET IMPACT ANALYSIS
    Elgart, J. F.
    Gonzalez, L.
    Perez Monteverde, A.
    Garrido Lecca, S.
    Aiello, E.
    Gagliardino, J. J.
    VALUE IN HEALTH, 2014, 17 (03) : A243 - A243
  • [10] Low-Dose Controlled-Release Phentermine/Topiramate (PHEN/TPM CR) For Weight Loss and Management of Type 2 Diabetes Mellitus (T2DM)
    Garvey, W. Timothy
    Peterson, Craig
    Troupin, Barbara
    OBESITY, 2010, 18 : S154 - S155
12345